Shared Scientific Focus
The current success of the Campus is underpinned by a shared focus in the science and innovation themes undertaken by the companies and academic researchers on site. The Campus research community is delivering research and innovation with a focus on key questions in biology that resonate with the Campus’ commercial community, with global investors, and society more widely.
This coherence has enabled breakthrough research and innovation opportunities to be captured, for example in areas such as antibody technologies. Current strengths and synergy between the academic research at the Babraham Institute and commercial development undertaken on the Campus include understanding fundamental and disease biology (with a particular focus on aging, immunology, cell signalling processes, genomics, epigenomics, lipidomics, proteomics), coupled with delivering the capabilities for drug discovery and development (with a particular focus on biologics drug discovery and development, development of AI and its applications in drug discovery, methods for identifying disease mechanism targeting, early clinical development, chemistry, and in vivo sciences).
These strengths and synergies are also supporting the development of thematic alliances as platforms for future breakthrough science, innovation and business models.